Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

Autor: Toyohara J; Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan., Vugts D; Amsterdam University Medical Center, Amsterdam, The Netherlands., Kiss OC; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany. o.kiss@hzdr.de., Todde S; University of Milano-Bicoccia, Tecnomed Foundation, Monza, Italy., Li XG; Turku PET Centre and Department of Chemistry, and InFLAMES Research Flagship Center, University of Turku, Turku, Finland., Liu Z; Peking University, Beijing, China., Yang Z; Peking University Cancer Hospital & Institute, Beijing, China., Gillings N; Copenhagen University Rigshospitalet, Copenhagen, Denmark., Cazzola E; Sacro Cuore Hospital, Verona, Italy., Szymanski W; University of Groningen, Groningen, The Netherlands., Meulen NV; Paul Scherrer Institute (PSI), Villigen, Switzerland., Reilly R; University of Toronto, Toronto, Canada., Taddei C; Life Molecular Imaging GmbH, Berlin, Germany., Schirrmacher R; University of Alberta, Edmonton, Canada., Li Z; Xiamen University, Xiamen, China., Lagebo YJ; Addis Ababa University, Addis Ababa, Ethiopia., Bentaleb N; National Center for Nuclear Energy, Science and Technology-CNESTEN, Rabat, Morocco., Souza Albernaz M; University Hospital Clementino Fraga Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Lapi S; University of Alabama at Birmingham, Birmingham, USA., Ramogida C; Simon Fraser University, Burnaby, Vancouver, Canada.; TRIUMF, Burnaby, Vancouver, Canada., Mukherjee A; Bhabha Atomic Research Center and Homi Bhabha National Institute, Mumbai, India., Ajenjo J; Molecular Imaging Program at Stanford (MIPS), Dept of Radiology, School of Medicine, Stanford University, Stanford, CA), USA., Deuther-Conrad W; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Leipzig, Germany., Bourdeau C; GIP Arronax, Nantes, France.

Publikováno v: EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2024 May 16; Vol. 9 (1), pp. 42. Date of Electronic Publication: 2024 May 16.

[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial.

Autor: Adams, H., van de Garde, E. M. W., Vugts, D. J., Grutters, J. C., Oyen, Wim. J.G., Keijsers, R. G.

Publikováno v: European Journal of Nuclear Medicine & Molecular Imaging; Jun2023, Vol. 50 Issue 7, p1929-1939, 11p, 1 Color Photograph, 1 Diagram, 2 Charts, 3 Graphs

First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during chemoradiotherapy in patients with non-small cell lung cancer using whole body PET.

Autor: Pouw JEE; Department of Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands.; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, Netherlands., Hashemi SMS; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, Netherlands.; Department of Pulmonary Medicine, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands., Huisman MC; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands., Wijngaarden JE; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands., Slebe M; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, Netherlands.; Department of Pulmonary Medicine, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands., Oprea-Lager DE; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands., Zwezerijnen GJC; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands., Vugts D; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands., Ulas EB; Department of Pulmonary Medicine, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands.; Cancer Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands., de Gruijl TD; Department of Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands.; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, Netherlands., Radonic T; Department of Pathology, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands., Senan S; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, Netherlands.; Department of Radiation Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands., Menke-van der Houven van Oordt CW; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, Netherlands.; Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands., Bahce I; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, Netherlands i.bahce@amsterdamumc.nl.; Department of Pulmonary Medicine, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Feb 01; Vol. 12 (2). Date of Electronic Publication: 2024 Feb 01.

Application of ⁸⁹Zr-DFO*-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibody.

Autor: Stergiou, N., Wuensche, T. E., Schreurs, M., Mes, I., Verlaan, M., Kooijman, E. J. M., Windhorst, A. D., Helboe, L., Vergo, S., Christensen, S., Asuni, A. A., Jensen, A., Van Dongen, G. A. M. S., Bang-Andersen, B., Vugts, D. J., Beaino, W.

Publikováno v: European Journal of Nuclear Medicine & Molecular Imaging; Apr2023, Vol. 50 Issue 5, p1306-1317, 12p, 3 Diagrams, 1 Chart, 3 Graphs